SCHEMBL26022985

SCHEMBL26022985

CCOC(=O)C1=Cc2c(ccc(Cl)c2NC)OC1C(F)(F)F

nearest known ligand 0.56

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 20/20 0.56
PTGS1 P23219 16/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5648714 0.88 PTGS2 (0.72) PTGS2PTGS1
SCHEMBL5645198 0.87 PTGS2 (0.58) PTGS2PTGS1
SCHEMBL5645484 0.86 PTGS2 (0.69) PTGS2PTGS1
SCHEMBL5642586 0.86 PTGS2 (0.57) PTGS2PTGS1
SCHEMBL5651209 0.85 PTGS2 (0.56) PTGS2PTGS1
SCHEMBL5646643 0.84 PTGS2 (0.63) PTGS2PTGS1
SCHEMBL27628667 0.82 PTGS2 (0.61) PTGS2PTGS1
SCHEMBL5670312 0.81 PTGS2 (0.51) PTGS2PTGS1
SCHEMBL14440943 0.81 PTGS2 (0.51) PTGS2PTGS1
SCHEMBL5646929 0.81 PTGS2 (0.51) PTGS2PTGS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4233854-A2 THERAPEUTIC FORMULATIONS AND USES THEREOF Piedmont Animal Health Inc. (US) 2023-08-30 EP disclosed